Ledger.Open graph →

SEC Form D · filed April 12, 2018

Eidos Therapeutics, Inc

Offering

$74.0M

Sold

$26.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Hoyoung Huh · Castro Valley, CADirector Eric Aguiar · SAN FRANCISCO, CADirector Rajeev Shah · Chelsea, MADirector Jonathan Fox · Seattle, WAExec Uma Sinha · SAN FRANCISCO, CAExec Neil Kumar · San Francisco, CAExec · Director Eric Aguiar · San Francisco, CADirector Christine Siu · Chicago, ILExec Rajeev Shah · San Francisco, CADirector Jonathan Fox · SAN FRANCISCO, CAExec Uma Sinha · SAN FRANCISCO, CAExec Hoyoung Huh · Redwood City, CADirector Neil Kumar · San Francisco, CAExec · Director Eric Aguiar · San Francisco, CADirector Christine Siu · SAN FRANCISCO, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗